Nonetheless, our current results provide evidence indicating that ephrinA5 can hinder the tumor suppressive signaling normally coupled with degradation of EphA2, thus allowing the oncogenic receptor to function at the HGSC cell membranes. Here, EPHA2 is linked to neoplasm.